133 related articles for article (PubMed ID: 8386899)
1. Some cellular and pathophysiological correlates of the inflammatory effects of a synthetic immunomodulatory agent, muramyl dipeptide (MDP).
Zídek Z; Franková D; Masek K
Agents Actions; 1993 Jan; 38(1-2):106-15. PubMed ID: 8386899
[TBL] [Abstract][Full Text] [Related]
2. Differences in proinflammatory activity of several immunomodulatory derivatives of muramyl dipeptide (MDP) with special reference to the mechanism of the MDP effects.
Zídek Z
Agents Actions; 1992 May; 36(1-2):136-45. PubMed ID: 1414682
[TBL] [Abstract][Full Text] [Related]
3. Edemagenic activity of aqueous form of muramyl dipeptide (MDP) in rats.
Zídek Z; Masek K
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):419-26. PubMed ID: 4079592
[TBL] [Abstract][Full Text] [Related]
4. T-cell-dependent immunobiological activity of a desmuramyl analog of muramyl dipeptide, adamantylamide dipeptide (AdDP), and D-isoglutamine.
Zídek Z; Masek K; Franková D; Flegel M
Int J Immunopharmacol; 1993 Jul; 15(5):631-7. PubMed ID: 8375945
[TBL] [Abstract][Full Text] [Related]
5. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen.
Leclerc C; Bourgeois E; Chedid L
Immunol Commun; 1979; 8(1):55-64. PubMed ID: 311334
[TBL] [Abstract][Full Text] [Related]
7. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
8. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation.
Zídek Z; Masek K; Sedivý F
Agents Actions; 1984 Jan; 14(1):72-5. PubMed ID: 6608216
[TBL] [Abstract][Full Text] [Related]
10. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture.
Dewhirst FE
Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120
[TBL] [Abstract][Full Text] [Related]
11. Marked enhancement of macrophage activation induced by synthetic muramyl dipeptide (MDP) conjugate using monoclonal anti-MDP antibodies.
Leclerc C; Bahr GM; Chedid L
Cell Immunol; 1984 Jul; 86(2):269-77. PubMed ID: 6733783
[TBL] [Abstract][Full Text] [Related]
12. Bilateral acute pyogenic conjunctivitis with iritis induced by unilateral topical application of bacterial peptidoglycan muramyl dipeptide in adult rabbits.
Langford MP; Foreman BD; Srur L; Ganley JP; Redens TB
Exp Eye Res; 2013 Nov; 116():324-36. PubMed ID: 24135297
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
[TBL] [Abstract][Full Text] [Related]
14. Immune-related edemagenic activity of glutamines and glutamic acid, components of immunomodulatory agents.
Zídek Z
Agents Actions; 1994 Oct; 42(3-4):163-6. PubMed ID: 7879704
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the growth of murine thymoma cell lines having different Lyt-phenotypes by MDP and MDP(D-D): macrophage-mediated inhibition of in vitro cell growth.
Phillips NC; Bahr GM; Modabber FZ; Chedid L
Int J Immunopharmacol; 1984; 6(6):577-85. PubMed ID: 6334660
[TBL] [Abstract][Full Text] [Related]
16. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine.
Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT
Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
Akasaki M; Takashi T; Kita Y; Tsukada W
Agents Actions; 1987 Oct; 22(1-2):144-50. PubMed ID: 3318323
[TBL] [Abstract][Full Text] [Related]
18. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
Parant M; Riveau G; Chedid L
Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
20. Uveitis induction in the rabbit by muramyl dipeptides.
Waters RV; Terrell TG; Jones GH
Infect Immun; 1986 Mar; 51(3):816-25. PubMed ID: 3949381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
